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NOTES ON SOME SERUM PROTEIN CHANGES 
IN VIRAL HEPATITIS — BIOCHEMICAL ASPECTS 
D. Hadzhilarska, P. Kokosharov, M. Radkov 
Serum'protein changes in*viral hepatitis%]ve been studied by various^attf. 
ors. Attempts have been "made to assess a "number of laboratory tests ' fW'!^ 
different .periods of the disease, failing to discoverChanges in terms of vncre^r 
sed, respectively, decreased values (1, 2, 4, 5> ?; 6\ 9, 10, 12, 13, 16, 19)ммм? 
Oqrgttetttion was foc îised on the changes in free serum amino acidsf-pt1^ 
tein fractions, total protim^immunoglobulins. and on the colloid stSfffifi^ 
tests thymol turbidity anc£Weltmann — in the first day of the patienV/^ajt 
mission to the clinic, tha-t isafter the beginning:of the icteric period. ***** 
Material and methods 
"' Eighty blood sera not containing, and 46 containing Australia antigen 
(hepetitis-associated antigen — HAA) were used in the study, at a control groyp 
of ten clinically healthy individuals without a past history of virabhepati-
tis, responding negatively against the Australia antigen. 
> Study of the Australia antigen was carried out using electrophoreticamraurra-
precipitation according to Pesendorfer and assoc, (18) free'amino acids — accor-
ding to Pashina (6), serum protein fractions through paper electrophoresis af-
iter Todorov (15), immunoglobulins after Mancini(17), total protein, thymol 
^turbidity test and Weltmann — according to routinely used methods. The 
data were elaborated statistically afted the method of variation analysis — 
Sepetliev (11). 
Results and discussion 
Among the studied in blood sera 14 free amino acids, not containing Aus 
Tal ia antigen, seven show elevated values, namely: cystine, lysine, histi-
dine, aspariginic acid, glycine, leucine (P<0.001) and serine (P<0.01) — 
Wable 1. 
The other amino acids, regardless of the rise, do not show statistically re-
l iable differences in comparison with control sera. In Australia-antigen con-
taining blood sera, the following amino acids are increased: cystine, lysine, 
histidine, aspariginic acid, serine, glycine, valine, leucine (P<0.001), and ar-
ginine (P<0.02), whereas phenylalanine is lowered (P<0.01). 
In the same sera, the listed below amino acids are increased relative to tho-
se not containing Australia antigen: lysine, histidine, aspariginic acid, alanine, 
valine (P<0.001), cystine and leucine (P<0.01), whereas tyrosine and pheny-
lalanine show a reduction, P<0.001 and P<0.05 respectively. 
Nowadays, the standpoint that viral hepatitis is an infectious disease with 
viral etiology has been universally adopted. In the opinion of Tihonenko (1966), 
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T a b l e I 
Naturally Occurring Amino Acids in Blood Sera of Viral Hepatitis Patients, 































































viral proteins are built up by the basic amino acids — arginine. lysine and hi­
stidine, and because of that their elevated values are worthy of notice. Certain­
ly, these amino acids are essential for man, but an eventual synthesis under 
the effect of an introduced viral information is by no means ruled out. 
Total protein is within normal limits at reduced albumins (P<0.001) and 
increased gammaglobulins, especially in Australia antigen containing sera 
<P<0.001) — Table 2. 
T a b l e 2 
Serum Protein Fractions in the Blood Sera of Viral Hepatitis 
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The albumin-globulin coefficient is lowered. These changes are essential for 
the elevated thymol turbidity test values (P<0.001). Of the immunoglobulins 
{Table 4), IgG (P<0:001 for sera not containing, and P<0.01 for those contai­
ning Australia antigen) and IgA (P<0.1, resp. P<0.001) show an appreciable 
increase. IgM is reduced in either types of sera, with statistical reliability in 
those containing Australia antigen (P<0.02). The elevated values of globu-
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lins, respectively IgG, and the low IgM values along with the other changes 
indicate that upon admission to the clinic, the patients with viral hepatitis are 
already in an advanced stage of the infectious process, and it is completely ju 
stifled to pose the question whether or not the occurrence of the icteric period 
should be considered as the peak period of the disease. 
T a b l e 
Quantitative Values of the Thymol and Weltmann Tests in Viral Hepatitlc 
Tests 
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T a b l e 4j 
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Changes in serum proteins in clinically manifested viral hepatitis and 
upon hospitalization disclose a late stage of the infectious process. Thus, the 
epidemiologic efficiency of «early» diagnosis is reduced, and along with that 
the question of a more active therapeutical intervention is raised. 
The constellation of the above indices, subjected to comparative study 
with various diseases simulating the early clinical picture of viral hepatitis, 
could eventually have a definite differential-diagnostical importance. 
Tracing of the dynamics of the above mentioned indicators in the blood 
sera of contacts with viral hepatitis patients, and detection of their earliest 
positivation would have an essential epidemiologic and clinical bearing, and 
because of that further studies along this line are mandatory. 
s 
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БИОХИМИЧЕСКИЕ АСПЕКТЫ НЕКОТОРЫХ ИЗМЕНЕНИЙ 
СЫВОРОТОЧНЫХ ПРОТЕИНОВ ПРИ ВИРУСНОМ ГЕПАТИТЕ 
Д. Хаджилорска, П. Кокошаров, М. Радков 
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Изменения сывороточных протеинов при клиническом проявлении 
вирусного гепатита и при поступлении в больничное заведение указывает 
•на. позднюю стадию инфекционного процесса. Это уменьшает эпидемиоло­
гическую эффективность раннего диагноза и в то же время ставит вопрос о 
более активном терапевтическом вмешательстве. 
Совокупность указанных показателей при сопоставлении их и при дру­
гих заболеваниях, напоминающих начальную клиническую картину ви­
русного гепатита, вероятно, мыло бы иметь определенное дифференци­
ально-диагностическое значение. 
•Прослеживание динамики вышеуказанных показателен в сыворотке 
крови контактирующих с больными вирусным гепатитом и установление 
их наиболее раннего позитивирования представляло бы значительный эпи­
демиологический и клинический интерес, что требует необходимости, даль­
нейшего изучения. 
A STUDY OF LYSOZYME (MURAMIDASE) ACTIVITY 
IN THE SERUM AND URINE 
O F PATIENTS WITH BLOOD DISEASES 
E . Yordanova, R. Marinova, R. Mishkova : 
In the past few years, researches in the lysozyme have greatly extended. 
It, is well known that the lysozyme is contained in the serum, in the urine —. 
in insignificant quantities, as well as in neutrophil granulocytes and mono-
cytes of the peripheral blood of healthy persons. Among bone marrow ele-
ments, lysozyme has been established in promyelocytes, and in the rather ma-
ture, white blood cells (1 , 5). 
Changes in this particular enzyme in the serum and urine of leukosis pa--
tients have been subjected to a comparatively more detailed study. In the l i -
terature the opinions are unanimous in terms of the lysozyme increase in pa-
tients with monocytoid type of acute leukosis and chronic myelogenic leu-
kosis where it is considered that changes in lysozyme have both diagnostic 
and prognostic value (2, 3, 4, 5, 7, 9). There are no literature reports in this• 
country concerning lysozyme studies in malignant hemopathies. 
The purpose of the present work is to try to find changes in muramidase 
in the serum and urine of patients with various systemic blood affections, as-' 
well as to determine their dependence on the type and stage of disease, and 
the effect of the treatment performed. 
Material and methods 
The study is conducted on a series of 76 clinically affected cases of which 
43. with leukosis diseases (acute leukosis, chronic myelogenic leukosis and 
chronic lymphatic leukosis), 20 with malignant lymphoblastoma, and 13 with 
other hemopathies (polycythemia vera, reticulosis). Forty seven practically 
healthy individuals were studied for control purposes. 
Quantitative lysozyme determination in the serum and urine was 
made after the method of Osserman and Lawlor, as modified by Zucker (8, 10). 
To about 100 ml 1 per cent agar (Difco) in 0.067 M sodium phosphate buffer 
(pH 6.2), thawed and cooled to 60° C, 60 mg Micrococcus lysodeicticus from 
a 24-hour agar culture was added. Following mixture, a determined quantity 
was decanted in petri dishes at 4 mm thickness of the layer. Using a needle 
with 3 mm diameter, small wells were formed in the agar, and filled with 
the material under study by means of a Pasteur's pipette. The batches were 
kept at room temperature for a duration of 24 hours, and thereafter the dia-
meter of the zones lysed by the enzyme was measured. Readings of the lyso-
zyme in mcg/ml were made after the semilogarithmic curve, built on the basis 
of data from standard dilutions of egg lysozyme because of the lack of a hu 
man one. Lysozyme activity recordings in mcg/ml egg lysozyme have been 
described in the literature. (9). 
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